Literature DB >> 9716339

Pneumatic retinopexy. A long term follow-up study.

C Lisle1, K K Mortensen, A K Sjølie.   

Abstract

PURPOSE: We have analysed the results of 48 consecutive cases of rhegmatogenous retinal detachment treated with pneumatic retinopexy in a long term follow-up study.
RESULTS: Thirty six of the original 48 patients were available to follow-up. We had an average follow-up period of 8.1 years and a 75% 7 year follow-up. Single operation success was achieved in 83% of patients. Redetachment occurred in 3 patients at 11, 30 and 33 months. Complications found included new breaks in 14%,, cystoid macular oedema in 8%,, and proliferative vitreoretinopathy in 3% of patients. No previously unreported complications were found in spite of the long follow-up time. Final anatomic success (after 1 or more operations) at 6 months post operatively was found in 97% of patients. At follow-up we found final anatomic success in all patients.
CONCLUSION: The use of pneumatic retinopexy instead of scleral buckling is discussed. We recommend the consideration of pneumatic retinopexy in uncomplicated selected cases of rhegmatogenous retinal detachment.

Entities:  

Mesh:

Year:  1998        PMID: 9716339     DOI: 10.1034/j.1600-0420.1998.760418.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

Review 1.  View 3: The case for pneumatic retinopexy.

Authors:  E R Holz; W F Mieler
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  Pneumatic retinopexy: success rate and complications.

Authors:  A A Zaidi; R Alvarado; A Irvine
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

3.  Anatomic, Visual, and Financial Outcomes for Traditional and Nontraditional Primary Pneumatic Retinopexy for Retinal Detachment.

Authors:  Jesse J Jung; John Cheng; Jane Y Pan; Daniel A Brinton; Quan V Hoang
Journal:  Am J Ophthalmol       Date:  2019-01-24       Impact factor: 5.258

4.  Long term results of pneumatic retinopexy.

Authors:  Amin F Ellakwa
Journal:  Clin Ophthalmol       Date:  2012-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.